These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 9514702)
21. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879 [TBL] [Abstract][Full Text] [Related]
22. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Xu H; Rizzo LV; Silver PB; Caspi RR Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700 [TBL] [Abstract][Full Text] [Related]
23. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis. Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006 [TBL] [Abstract][Full Text] [Related]
24. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237 [TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats. Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865 [TBL] [Abstract][Full Text] [Related]
26. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084 [TBL] [Abstract][Full Text] [Related]
27. Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats. El-Sheikh A; Suarez-Pinzon WL; Power RF; Rabinovitch A J Autoimmun; 1999 Mar; 12(2):109-19. PubMed ID: 10047431 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of autoimmune uveitis by anti-CD4 antibody. Atalla L; Linker-Israeli M; Steinman L; Rao NA Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1264-70. PubMed ID: 1973156 [TBL] [Abstract][Full Text] [Related]
29. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. Caspi RR; Roberge FG; McAllister CG; el-Saied M; Kuwabara T; Gery I; Hanna E; Nussenblatt RB J Immunol; 1986 Feb; 136(3):928-33. PubMed ID: 2416842 [TBL] [Abstract][Full Text] [Related]
30. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Kawashima H; Fujino Y; Mochizuki M Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329 [TBL] [Abstract][Full Text] [Related]
31. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443 [TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837 [TBL] [Abstract][Full Text] [Related]
33. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. Rizzo LV; Miller-Rivero NE; Chan CC; Wiggert B; Nussenblatt RB; Caspi RR J Clin Invest; 1994 Oct; 94(4):1668-72. PubMed ID: 7929845 [TBL] [Abstract][Full Text] [Related]
35. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. Gregerson DS; Obritsch WF; Donoso LA J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817 [TBL] [Abstract][Full Text] [Related]
36. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Yoshida M; Kezuka T; Streilein JW Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of S-antigen-induced experimental autoimmune uveoretinitis by active immunization against anti-idiotypic antibody to an S-antigen epitope. de Kozak Y; Mirshahi M; Boucheix C; Faure JP Reg Immunol; 1992; 4(3):168-74. PubMed ID: 1284615 [TBL] [Abstract][Full Text] [Related]
38. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707 [TBL] [Abstract][Full Text] [Related]
39. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin. Kohno H; Sakai T; Saito S; Okano K; Kitahara K Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229 [TBL] [Abstract][Full Text] [Related]
40. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis. Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]